WESTMINSTER

CAPSTONE™ Mission Accomplished and More Left to Go!

Retrieved on: 
星期三, 五月 29, 2024
Morehead State University, NASA, MSU, SBIR, Moon, Spacecraft, Silicon, CubeSat, Electron, Lunar Gateway, Small business, Telemetry, NRHO, CSAC, DSN, Atomic clock, Communication, Kennedy Space Center, SDL, NASA Deep Space Network, Communications satellite

Bradley Cheetham, Advanced Space’s President and CEO, stated, “This mission has not been easy.

Key Points: 
  • Bradley Cheetham, Advanced Space’s President and CEO, stated, “This mission has not been easy.
  • CAPSTONE has spent over 18 months accomplishing all of its operational objectives and taking on some additional roles as well.
  • The Artemis Campaign Development Division within NASA’s Exploration Systems Development Mission Directorate supported the launch and mission operations.
  • Providing telemetry, tracking and control services for NASA and commercial space missions and to engage university students in deep space mission operations.

ZimVie to Participate in Upcoming Investor Conferences

Retrieved on: 
星期四, 五月 16, 2024
PALM, BEACH, Conference

PALM BEACH GARDENS, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced that the company will be participating in two upcoming investor conferences.

Key Points: 
  • PALM BEACH GARDENS, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced that the company will be participating in two upcoming investor conferences.
  • ZimVie will be presenting at the upcoming Stifel 2024 Jaws & Paws Conference.
  • ZimVie’s management is scheduled to present on Thursday, May 30, 2024, at 11:30 a.m. Eastern Time.
  • ZimVie’s management will also be presenting at the 45th Annual Goldman Sachs Global Healthcare Conference on Wednesday, June 12, 2024, at 3:20 p.m. Eastern Time.

ZimVie Reports First Quarter 2024 Financial Results

Retrieved on: 
星期三, 五月 8, 2024
Sale, Adjustment, Completeness, PALM, EPS

We recently paid down $275 million of debt and re-focused our organization as a pure-play dental company with a comprehensive and industry leading portfolio.”

Key Points: 
  • We recently paid down $275 million of debt and re-focused our organization as a pure-play dental company with a comprehensive and industry leading portfolio.”
    First Quarter 2024 Financial Results: Continuing Operations
    Third party net sales for the first quarter of 2024 were $118.2 million, a decrease of 1.6% on a reported basis and 1.4% in constant currency[1], versus the first quarter of 2023.
  • Net loss for the first quarter of 2024 was ($11.5) million, a reduction of $4.9 million versus a net loss of ($16.4) million in the first quarter of 2023.
  • Adjusted net income[1] for the first quarter of 2024 was $2.2 million, an increase of $1.9 million versus the first quarter of 2023.
  • Full Year 2024 Continuing Operations Financial Guidance:
    Projected Year Ending December 31, 2024

KPA Flex Software Enhances Construction Safety and Compliance with Advanced Features

Retrieved on: 
星期一, 五月 6, 2024
Construction, Flex, ERP, EHS, Organization, KPA, Natural gas

WESTMINSTER, Colo., May 06, 2024 (GLOBE NEWSWIRE) -- KPA , a leading provider of Environment, Health, and Safety (EHS) compliance solutions, announced the release of new features in the KPA Flex software platform that are specifically tailored for construction safety programs to streamline efficiency, increase real-time visibility, and foster a robust safety culture.

Key Points: 
  • WESTMINSTER, Colo., May 06, 2024 (GLOBE NEWSWIRE) -- KPA , a leading provider of Environment, Health, and Safety (EHS) compliance solutions, announced the release of new features in the KPA Flex software platform that are specifically tailored for construction safety programs to streamline efficiency, increase real-time visibility, and foster a robust safety culture.
  • To achieve better visibility into construction compliance, KPA Flex enables users to capture insights in the field through mobile and then provides real-time information with advanced reporting and dashboards.
  • With the launch of these new features, KPA aims to empower construction teams to build safely and efficiently with industry-leading safety management software.
  • Organizations can explore how KPA's Flex software can transform construction safety and compliance for their organization.

ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update

Retrieved on: 
星期四, 四月 25, 2024
University, Separable space, General counsel, Atlas, Research, Plan, Employment, ARCA, Internal Revenue Code, Senior, Consultant, Acquisition, Accounting, Medicine, Committee, G&A, Pharmaceutical industry

WESTMINSTER, Colo., April 25, 2024 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), (the “Company”) a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today reported first quarter 2024 financial results and provided a corporate update.

Key Points: 
  • WESTMINSTER, Colo., April 25, 2024 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), (the “Company”) a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today reported first quarter 2024 financial results and provided a corporate update.
  • In April 2022, ARCA established a Special Committee of the board of directors (the “Board”) of ARCA to conduct a comprehensive review of strategic alternatives.
  • In connection with Dr. Bristow’s separation, ARCA and Dr. Bristow entered into a separation agreement (the “Separation Agreement”) on April 3, 2024.
  • Total operating expenses for the quarter ended March 31, 2024 were $2.5 million compared to $1.8 million for the first quarter 2023.

ZimVie to Report First Quarter Financial Results on May 8, 2024

Retrieved on: 
星期三, 四月 24, 2024
Webcast, BEACH, PALM

PALM BEACH GARDENS, Fla., April 24, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the first quarter 2024 after market close on Wednesday, May 8, 2024.

Key Points: 
  • PALM BEACH GARDENS, Fla., April 24, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the first quarter 2024 after market close on Wednesday, May 8, 2024.
  • Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.
  • Those interested in listening to the conference call should register online here .
  • Participants are encouraged to register more than 15 minutes before the start of the call.

BioLargo to Present at The LD Micro Invitational XIV

Retrieved on: 
星期一, 三月 25, 2024
Sofitel New York Hotel, OTCQB, PFAS, Water

Westminster, California--(Newsfile Corp. - March 25, 2024) - BioLargo, Inc. (OTCQB: BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, announced today that it will be presenting at the 14th annual LD Micro Invitational investor conference on April 9, 2024, at 2:30 PM ET, at the Sofitel New York hotel.

Key Points: 
  • Westminster, California--(Newsfile Corp. - March 25, 2024) - BioLargo, Inc. (OTCQB: BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, announced today that it will be presenting at the 14th annual LD Micro Invitational investor conference on April 9, 2024, at 2:30 PM ET, at the Sofitel New York hotel.
  • Dennis P. Calvert, President and CEO of BioLargo, will be giving the presentation.
  • Mr. Calvert's presentation will focus on the company's 2023 financial results, in which revenues more than doubled from 2022, as well as the progress of multiple commercial initiatives including consumer pet odor control, the company's liquid sodium battery energy storage system, and the company's PFAS water treatment business.

ARCA biopharma and Oruka Therapeutics Announce Merger Agreement

Retrieved on: 
星期三, 四月 3, 2024
Paragon, Freedom, Psoriasis, Biotechnology, ARCA, Disease, Patient, Paradigm, Psoriatic arthritis, Standard of care, Doctor of Philosophy, Investment, RTW, Engineering, Pharmaceutical industry

WESTMINSTER, Colo. and WALTHAM, Mass., April 03, 2024 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (NASDAQ: ABIO) (“ARCA”), and Oruka Therapeutics (“Oruka”), a privately held biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases, including plaque psoriasis, announced today that they have entered into a definitive agreement to combine the companies in an all-stock transaction. The resulting entity will focus on advancing Oruka’s pipeline of potentially best-in-class biologics, including ORKA-001 (an IL-23p19 inhibitor) and ORKA-002 (an IL-17A/F inhibitor). Upon completion of the merger, the combined company plans to operate under the name Oruka Therapeutics, Inc. and trade on Nasdaq under the ticker symbol “ORKA”.

Key Points: 
  • Upon completion of the merger, the combined company plans to operate under the name Oruka Therapeutics, Inc. and trade on Nasdaq under the ticker symbol “ORKA”.
  • In addition, prior to closing of the merger, ARCA expects to declare a cash dividend to the pre-merger ARCA stockholders equal to the amount by which ARCA’s net cash exceeds $5 million.
  • “Our mission at Oruka is to offer people affected with chronic skin diseases the most possible freedom from their condition.
  • Oruka is the third company founded based on assets generated by Paragon Therapeutics (“Paragon”).

ZimVie Announces Closing of Sale of Spine Business

Retrieved on: 
星期一, 四月 1, 2024
GAAP, Partnership, Dental, Patient, H.I.G. Capital, PALM, Sale, BEACH

PALM BEACH GARDENS, Fla., April 01, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced that it has closed the previously communicated sale of its Spine business to an affiliate of H.I.G.

Key Points: 
  • PALM BEACH GARDENS, Fla., April 01, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced that it has closed the previously communicated sale of its Spine business to an affiliate of H.I.G.
  • Capital for $375 million in total consideration, including $315 million in cash and a $60 million promissory note.
  • “The completion of the sale of our Spine business is the culmination of months of partnership with H.I.G.
  • Capital and years of commitment from our global Spine team members; I would like to thank everyone for their immense contributions,” said Vafa Jamali, President and Chief Executive Officer.

ZimVie to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Retrieved on: 
星期三, 三月 27, 2024
Webcast, Conference

WESTMINSTER, Colo., March 27, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced management will participate in the upcoming 23rd Annual Needham Virtual Healthcare Conference.

Key Points: 
  • WESTMINSTER, Colo., March 27, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced management will participate in the upcoming 23rd Annual Needham Virtual Healthcare Conference.
  • Management will be presenting on Wednesday, April 10th, 2024 at 3:00 p.m. Eastern Time / 12:00 p.m. Pacific Time.
  • A live webcast of the event, as well as an archived recording will be available on the “Investors” section of the company’s website at: www.zimvie.com .
  • The webcast will be archived and available for replay for at least 90 days after the event.